1.Role of LRRN3 in the cerebellum postnatal development in rats.
Jing YANG ; Fang LI ; Li QIU ; Xuegang LUO ; He HUANG
Journal of Central South University(Medical Sciences) 2011;36(5):424-429
OBJECTIVE:
To explore the effect and possible mechanism of LRRN3 in the cerebellum postnatal development in rats.
METHODS:
New born rats were randomly divided into an experimental group and a control group, and each group included 3 sub-groups of different time points. Behavioral experiment, hematoxylin-eosin (HE) staining and immunohistochemistry were used to evaluate the effects of anti-LRRN3 injection on the cerebellum development in new born rats.
RESULTS:
Compared with the control, the balance ability in the experiment group was weak, and there was significant difference in the static balance between the 2 groups (P<0.05). HE staining showed that molecular layer (ML) grew thicker from the 7th day to the 21st day after birth,and the structure changed dynamically. Vesicular glutamate transporter 1(VGluT1) expression was positive in the cerebellum of all groups, and the positive ML grew thicker from the 7th day to the 21st day after birth. Compared with the control, there was no obvious difference between the 2 groups on the 7th day after birth (P<0.05), while on the 14th day and the 21st day, there was significant difference (P<0.01).
CONCLUSION
LRRN3 plays an important role in cerebellum postnatal development. Anti-LRRN3 antibody injection may down-regulate the expression of VGluT1, reduce the synapse formation in the molecular layer,decrease the thickness of ML and inhibit the growth of cerebellum cortex and the functional neural circuit formation.
Animals
;
Animals, Newborn
;
Cerebellum
;
growth & development
;
metabolism
;
Female
;
Male
;
Nerve Tissue Proteins
;
physiology
;
Random Allocation
;
Rats
;
Rats, Sprague-Dawley
;
Vesicular Glutamate Transport Protein 1
;
metabolism
2.Spinal CCL2 Promotes Central Sensitization, Long-Term Potentiation, and Inflammatory Pain via CCR2: Further Insights into Molecular, Synaptic, and Cellular Mechanisms.
Rou-Gang XIE ; Yong-Jing GAO ; Chul-Kyu PARK ; Ning LU ; Ceng LUO ; Wen-Ting WANG ; Sheng-Xi WU ; Ru-Rong JI
Neuroscience Bulletin 2018;34(1):13-21
Mounting evidence supports an important role of chemokines, produced by spinal cord astrocytes, in promoting central sensitization and chronic pain. In particular, CCL2 (C-C motif chemokine ligand 2) has been shown to enhance N-methyl-D-aspartate (NMDA)-induced currents in spinal outer lamina II (IIo) neurons. However, the exact molecular, synaptic, and cellular mechanisms by which CCL2 modulates central sensitization are still unclear. We found that spinal injection of the CCR2 antagonist RS504393 attenuated CCL2- and inflammation-induced hyperalgesia. Single-cell RT-PCR revealed CCR2 expression in excitatory vesicular glutamate transporter subtype 2-positive (VGLUT2) neurons. CCL2 increased NMDA-induced currents in CCR2/VGLUT2 neurons in lamina IIo; it also enhanced the synaptic NMDA currents evoked by dorsal root stimulation; and furthermore, it increased the total and synaptic NMDA currents in somatostatin-expressing excitatory neurons. Finally, intrathecal RS504393 reversed the long-term potentiation evoked in the spinal cord by C-fiber stimulation. Our findings suggest that CCL2 directly modulates synaptic plasticity in CCR2-expressing excitatory neurons in spinal lamina IIo, and this underlies the generation of central sensitization in pathological pain.
Animals
;
Benzoxazines
;
pharmacology
;
therapeutic use
;
Chemokine CCL2
;
antagonists & inhibitors
;
genetics
;
metabolism
;
pharmacology
;
Excitatory Amino Acid Agents
;
pharmacology
;
Excitatory Amino Acid Agonists
;
pharmacology
;
Female
;
Freund's Adjuvant
;
toxicity
;
Hyperalgesia
;
chemically induced
;
metabolism
;
prevention & control
;
Long-Term Potentiation
;
drug effects
;
physiology
;
Luminescent Proteins
;
genetics
;
metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Mice, Transgenic
;
Myelitis
;
chemically induced
;
drug therapy
;
metabolism
;
Neurons
;
drug effects
;
Pain Management
;
Somatostatin
;
genetics
;
metabolism
;
Spinal Cord
;
cytology
;
Spiro Compounds
;
pharmacology
;
therapeutic use
;
Vesicular Glutamate Transport Protein 2
;
genetics
;
metabolism
;
Vesicular Inhibitory Amino Acid Transport Proteins
;
genetics
;
metabolism
3.Localization of vesicular glutamate transporters in the peripheral vestibular system of rat.
Yuan WANG ; You-Wang PANG ; Yu-Lin DONG ; Fu-Xing ZHANG ; Jin-Lian LI ; Yun-Qing LI
Neuroscience Bulletin 2007;23(3):175-179
OBJECTIVETo examine the vesicular glutamate transporters (VGluTs: VGluT1-VGluT3) in the peripheral vestibular system.
METHODSThe vestibular structures, including Scarpa's ganglion (vestibular ganglion, VG), maculae of utricle and saccule, and ampullary cristae, from normal Sprague-Dawley rats were processed immunohistochemically for VGluTs, by avidin-biotinylated peroxidase complex method, with 3-3'-diaminobenzidine (DAB) as chromogen.
RESULTS(1) VGluT1 was localized to partial neurons of VG and to the putative primary afferent fibers innervating vestibular end-organs. (2) Intense VGluT3 immunoreactivity was detected in large number of sensory epithelia cells, and weak labeling of VGluT3-positive afferent fibers was in the maculae and ampullary cristae. (3) No or very weak VGluT2 immunoreactivity was observed in the VG and acoustic maculae.
CONCLUSIONThese results provide the morphological support that glutamate exists in the peripheral vestibular system, and it may play an important role in the centripetal vestibular transmission.
Acoustic Maculae ; metabolism ; Animals ; Neurons ; metabolism ; Rats ; Rats, Sprague-Dawley ; Vesicular Glutamate Transport Proteins ; classification ; metabolism ; Vestibule, Labyrinth ; metabolism ; Vestibulocochlear Nerve ; cytology ; metabolism
4.Glutaminergic neurons expressing c-Fos in the brainstem and amygdala participate in signal transmission and integration of sweet taste.
Xiao-lin ZHAO ; Jian-qun YAN ; Ke CHEN ; Xue-juan YANG ; Jin-rong LI ; Yuan ZHANG
Journal of Southern Medical University 2011;31(7):1138-1141
OBJECTIVETo examine the role of glutaminergic neurons in the transmission and integration of the sweat taste information in the brain stem and the amygdala.
METHODSConscious Sprague-Dawley rats were subjected to oral sweet taste or water (control) stimulations. The activated neurons were identified by detecting c-Fos expression in taste-related brain areas, and the glutaminergic neurons by detecting vesicular glutamate transpoter-3 (VGLUT3).
RESULTSCompared with control group, the rats with oral sucrose solution stimulation exhibited significantly increased c-Fos-expressing and double-labeled neurons in the nucleus of the solitary tract (NST), the parabrachial nucleus (PBN) and the amygdala.
CONCLUSIONNeurons in the NST, PBN and amygdala are activated after oral sweet taste stimulation. The sweet taste perception at different levels in the CNS is partly mediated by glutamate.
Amygdala ; physiology ; Animals ; Brain Stem ; physiology ; Glutamic Acid ; metabolism ; Male ; Neurons ; metabolism ; physiology ; Proto-Oncogene Proteins c-fos ; metabolism ; Rats ; Rats, Sprague-Dawley ; Signal Transduction ; Solitary Nucleus ; cytology ; physiology ; Sucrose ; administration & dosage ; metabolism ; Taste Perception ; physiology ; Vesicular Glutamate Transport Proteins ; metabolism
5.A Critical Time-Window for the Selective Induction of Hippocampal Memory Consolidation by a Brief Episode of Slow-Wave Sleep.
Yi LU ; Zheng-Gang ZHU ; Qing-Qing MA ; Yun-Ting SU ; Yong HAN ; Xiaodong WANG ; Shumin DUAN ; Yan-Qin YU
Neuroscience Bulletin 2018;34(6):1091-1099
Although extensively studied, the exact role of sleep in learning and memory is still not very clear. Sleep deprivation has been most frequently used to explore the effects of sleep on learning and memory, but the results from such studies are inevitably complicated by concurrent stress and distress. Furthermore, it is not clear whether there is a strict time-window between sleep and memory consolidation. In the present study we were able to induce time-locked slow-wave sleep (SWS) in mice by optogenetically stimulating GABAergic neurons in the parafacial zone (PZ), providing a direct approach to analyze the influences of SWS on learning and memory with precise time-windows. We found that SWS induced by light for 30 min immediately or 15 min after the training phase of the object-in-place task significantly prolonged the memory from 30 min to 6 h. However, induction of SWS 30 min after the training phase did not improve memory, suggesting a critical time-window between the induction of a brief episode of SWS and learning for memory consolidation. Application of a gentle touch to the mice during light stimulation to prevent SWS induction also failed to improve memory, indicating the specific role of SWS, but not the activation of PZ GABAergic neurons itself, in memory consolidation. Similar influences of light-induced SWS on memory consolidation also occurred for Y-maze spatial memory and contextual fear memory, but not for cued fear memory. SWS induction immediately before the test phase had no effect on memory performance, indicating that SWS does not affect memory retrieval. Thus, by induction of a brief-episode SWS we have revealed a critical time window for the consolidation of hippocampus-dependent memory.
Animals
;
Cues
;
Electroencephalography
;
Electromyography
;
Evoked Potentials, Motor
;
physiology
;
Fear
;
psychology
;
Glutamate Decarboxylase
;
metabolism
;
Hippocampus
;
physiology
;
Light
;
Luminescent Proteins
;
genetics
;
metabolism
;
Maze Learning
;
physiology
;
Memory Consolidation
;
physiology
;
Mice
;
Mice, Inbred C57BL
;
Mice, Transgenic
;
Sleep Deprivation
;
Sleep, Slow-Wave
;
physiology
;
Time Factors
;
Vesicular Inhibitory Amino Acid Transport Proteins
;
genetics
;
metabolism
6.Losartan Prevents Maladaptive Auditory-Somatosensory Plasticity After Hearing Loss via Transforming Growth Factor-β Signaling Suppression
Seog Kyun MUN ; Kyu Hee HAN ; Jong Tae BAEK ; Suk Won AHN ; Hyun Sang CHO ; Mun Young CHANG
Clinical and Experimental Otorhinolaryngology 2019;12(1):33-39
OBJECTIVES: Hearing loss disrupts the balance of auditory-somatosensory inputs in the cochlear nucleus (CN) of the brainstem, which has been suggested to be a mechanism of tinnitus. This disruption results from maladaptive auditory-somatosensory plasticity, which is a form of axonal sprouting. Axonal sprouting is promoted by transforming growth factor (TGF)-β signaling, which can be inhibited by losartan. We investigated whether losartan prevents maladaptive auditory-somatosensory plasticity after hearing loss. METHODS: The study consisted of two stages: determining the time course of auditory-somatosensory plasticity following hearing loss and preventing auditory-somatosensory plasticity using losartan. In the first stage, rats were randomly divided into two groups: a control group that underwent a sham operation and a deaf group that underwent cochlea ablation on the left side. CNs were harvested 1 and 2 weeks after surgery. In the second stage, rats were randomly divided into either a saline group that underwent cochlear ablation on the left side and received normal saline or a losartan group that underwent cochlear ablation on the left side and received losartan. CNs were harvested 2 weeks after surgery. Hearing was estimated with auditory brainstem responses (ABRs). Western blotting was performed for vesicular glutamate transporter 1 (VGLUT1), reflecting auditory input; vesicular glutamate transporter 2 (VGLUT2), reflecting somatosensory input; growth-associated protein 43 (GAP-43), reflecting axonal sprouting; and p-Smad2/3. RESULTS: Baseline ABR thresholds before surgery ranged from 20 to 35 dB sound pressure level. After cochlear ablation, ABR thresholds were higher than 80 dB. In the first experiment, VGLUT2/VGLUT1 ratios did not differ significantly between the control and deaf groups 1 week after surgery. At 2 weeks after surgery, the deaf group had a significantly higher VGLUT2/VGLUT1 ratio compared to the control group. In the second experiment, the losartan group had a significantly lower VGLUT2/VGLUT1 ratio along with significantly lower p-Smad3 and GAP-43 levels compared to the saline group. CONCLUSION: Losartan might prevent axonal sprouting after hearing loss by blocking TGF-β signaling thereby preventing maladaptive auditory-somatosensory plasticity.
Animals
;
Axons
;
Blotting, Western
;
Brain Stem
;
Cochlea
;
Cochlear Nucleus
;
Evoked Potentials, Auditory, Brain Stem
;
GAP-43 Protein
;
Hearing Loss
;
Hearing
;
Losartan
;
Plastics
;
Rats
;
Tinnitus
;
Transforming Growth Factors
;
Vesicular Glutamate Transport Protein 1
;
Vesicular Glutamate Transport Protein 2
7.Sexual Dimorphism of Inputs to the Lateral Habenula in Mice.
Xue LIU ; Hongren HUANG ; Yulin ZHANG ; Liping WANG ; Feng WANG
Neuroscience Bulletin 2022;38(12):1439-1456
The lateral habenula (LHb), which is a critical neuroanatomical hub and a regulator of midbrain monoaminergic centers, is activated by events resulting in negative valence and contributes to the expression of both appetitive and aversive behaviors. However, whole-brain cell-type-specific monosynaptic inputs to the LHb in both sexes remain incompletely elucidated. In this study, we used viral tracing combined with in situ hybridization targeting vesicular glutamate transporter 2 (vGlut2) and glutamic acid decarboxylase 2 (Gad2) to generate a comprehensive whole-brain atlas of inputs to glutamatergic and γ-aminobutyric acid (GABA)ergic neurons in the LHb. We found >30 ipsilateral and contralateral brain regions that projected to the LHb. Of these, there were significantly more monosynaptic LHb-projecting neurons from the lateral septum, anterior hypothalamus, dorsomedial hypothalamus, and ventromedial hypothalamus in females than in males. More interestingly, we found a stronger GABAergic projection from the medial septum to the LHb in males than in females. Our results reveal a comprehensive connectivity atlas of glutamatergic and GABAergic inputs to the LHb in both sexes, which may facilitate a better understanding of sexual dimorphism in physiological and pathological brain functions.
Animals
;
Male
;
Mice
;
Glutamic Acid/metabolism*
;
Habenula/metabolism*
;
Hypothalamus/metabolism*
;
Neural Pathways/physiology*
;
Sex Characteristics
;
Vesicular Glutamate Transport Protein 2/metabolism*
;
Female
8.Vesicular Glutamate Transporter 1 (VGLUT1)- and VGLUT2-containing Terminals on the Rat Jaw-closing γ-Motoneurons
Sook Kyung PARK ; Jae Hyun HONG ; Jae Kwang JUNG ; Hyoung Gon KO ; Yong Chul BAE
Experimental Neurobiology 2019;28(4):451-457
Currently, compared to jaw-closing (JC) α-motoneurons, the information on the distribution and morphology of glutamatergic synapses on the jaw-closing (JC) γ-motoneurons, which may help elucidate the mechanism of isometric contraction of the JC muscle, is very limited. This study investigated the distribution and ultrastructural features of vesicular glutamate transporter 1 (VGLUT1)- and VGLUT2-immunopositive (+) axon terminals (boutons) on JC γ-motoneurons by retrograde tracing with horseradish peroxidase, electron microscopic immunocytochemistry, and quantitative analysis. About 35% of the boutons on identified JC γ-motoneurons were VGLUT+, and of those, 99% were VGLUT2+. The fraction of VGLUT1+ boutons of all boutons and the percentage of membrane of JC γ-motoneurons covered by these boutons were significantly lower than those for the JC α-motoneurons, revealed in our previous work. The bouton volume, mitochondrial volume, and active zone area of the VGLUT2+ boutons on the JC γ-motoneurons were uniformly small. These findings suggest that the JC γ-motoneurons, in contrast to the JC α-motoneurons, receive generally weak glutamatergic synaptic input almost exclusively from VGLUT2+ premotoneurons that form direct synapse with motoneurons.
Animals
;
Horseradish Peroxidase
;
Immunohistochemistry
;
Isometric Contraction
;
Membranes
;
Microscopy, Electron
;
Mitochondrial Size
;
Motor Neurons
;
Presynaptic Terminals
;
Rats
;
Synapses
;
Vesicular Glutamate Transport Protein 1
9.Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model.
Yanyan WANG ; Yong WANG ; Junhua LIU ; Xiaomin WANG
Neuroscience Bulletin 2018;34(3):476-484
Previous studies have shown that electroacupuncture (EA) promotes recovery of motor function in Parkinson's disease (PD). However the mechanisms are not completely understood. Clinically, the subthalamic nucleus (STN) is a critical target for deep brain stimulation treatment of PD, and vesicular glutamate transporter 1 (VGluT1) plays an important role in the modulation of glutamate in the STN derived from the cortex. In this study, a 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD was treated with 100 Hz EA for 4 weeks. Immunohistochemical analysis of tyrosine hydroxylase (TH) showed that EA treatment had no effect on TH expression in the ipsilateral striatum or substantia nigra pars compacta, though it alleviated several of the parkinsonian motor symptoms. Compared with the hemi-parkinsonian rats without EA treatment, the 100 Hz EA treatment significantly decreased apomorphine-induced rotation and increased the latency in the Rotarod test. Notably, the EA treatment reversed the 6-OHDA-induced down-regulation of VGluT1 in the STN. The results demonstrated that EA alleviated motor symptoms and up-regulated VGluT1 in the ipsilateral STN of hemi-parkinsonian rats, suggesting that up-regulation of VGluT1 in the STN may be related to the effects of EA on parkinsonian motor symptoms via restoration of function in the cortico-STN pathway.
Adrenergic Agents
;
toxicity
;
Animals
;
Apomorphine
;
pharmacology
;
Disease Models, Animal
;
Dopamine Agonists
;
pharmacology
;
Electroacupuncture
;
methods
;
Functional Laterality
;
drug effects
;
Male
;
Medial Forebrain Bundle
;
injuries
;
Motor Activity
;
drug effects
;
physiology
;
Neurons
;
drug effects
;
metabolism
;
Oxidopamine
;
toxicity
;
Parkinson Disease, Secondary
;
chemically induced
;
physiopathology
;
therapy
;
Rats
;
Rats, Sprague-Dawley
;
Subthalamic Nucleus
;
drug effects
;
metabolism
;
pathology
;
Tyrosine 3-Monooxygenase
;
metabolism
;
Up-Regulation
;
drug effects
;
physiology
;
Vesicular Glutamate Transport Protein 1
;
metabolism